These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 19548019)
1. Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series. Armamento-Villareal R; Napoli N; Diemer K; Watkins M; Civitelli R; Teitelbaum S; Novack D Calcif Tissue Int; 2009 Jul; 85(1):37-44. PubMed ID: 19548019 [TBL] [Abstract][Full Text] [Related]
3. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study. Chapurlat RD; Arlot M; Burt-Pichat B; Chavassieux P; Roux JP; Portero-Muzy N; Delmas PD J Bone Miner Res; 2007 Oct; 22(10):1502-9. PubMed ID: 17824840 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis. Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613 [TBL] [Abstract][Full Text] [Related]
5. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major. Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169 [TBL] [Abstract][Full Text] [Related]
6. Association of low-energy femoral shaft fractures and bisphosphonate use. Fowler JR; Craig MR Orthopedics; 2012 Jan; 35(1):e38-40. PubMed ID: 22229611 [TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. Schneider JP Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578 [TBL] [Abstract][Full Text] [Related]
8. [Bone Cell Biology Assessed by Microscopic Approach. The effects of bisphosphonates on bone remodeling, microdamage accumulation and fracture repair process]. Mashiba T Clin Calcium; 2015 Oct; 25(10):1537-40. PubMed ID: 26412734 [TBL] [Abstract][Full Text] [Related]
9. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?]. Yamaguchi T; Sugimoto T Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263 [TBL] [Abstract][Full Text] [Related]
10. Atypical fractures as a potential complication of long-term bisphosphonate therapy. Sellmeyer DE JAMA; 2010 Oct; 304(13):1480-4. PubMed ID: 20924014 [TBL] [Abstract][Full Text] [Related]
11. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. Komatsubara S; Mori S; Mashiba T; Li J; Nonaka K; Kaji Y; Akiyama T; Miyamoto K; Cao Y; Kawanishi J; Norimatsu H J Bone Miner Res; 2004 Jun; 19(6):999-1005. PubMed ID: 15125797 [TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation in fracture patients treated with oral bisphosphonates. Abrahamsen B; Eiken P; Brixen K J Intern Med; 2009 May; 265(5):581-92. PubMed ID: 19141097 [TBL] [Abstract][Full Text] [Related]
13. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis]. Fukunaga M Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266 [TBL] [Abstract][Full Text] [Related]
14. Teriparatide following bisphosphonates: initial and long-term effects on microarchitecture and bone remodeling at the human iliac crest. Jobke B; Pfeifer M; Minne HW Connect Tissue Res; 2009; 50(1):46-54. PubMed ID: 19212852 [TBL] [Abstract][Full Text] [Related]